Gout and the risk of age-related macular degeneration in the elderly.

<h4>Objective</h4>To assess whether gout is associated with incident age-related macular degeneration (AMD).<h4>Methods</h4>We used the 5% Medicare claims data from 2006-12 for all beneficiaries who were enrolled in Medicare fee-for-service (Parts A, B) and not enrolled in a...

Full description

Saved in:
Bibliographic Details
Main Authors: Jasvinder A Singh, John D Cleveland
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199562&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850044508552560640
author Jasvinder A Singh
John D Cleveland
author_facet Jasvinder A Singh
John D Cleveland
author_sort Jasvinder A Singh
collection DOAJ
description <h4>Objective</h4>To assess whether gout is associated with incident age-related macular degeneration (AMD).<h4>Methods</h4>We used the 5% Medicare claims data from 2006-12 for all beneficiaries who were enrolled in Medicare fee-for-service (Parts A, B) and not enrolled in a Medicare Advantage Plan, and resided in the U.S. People were censored at the occurrence of new diagnosis of AMD, death or the end of study (12/31/2012), whichever occurred first. We used multivariable-adjusted Cox regression analyses to assess the association of gout with incident AMD, adjusted for demographics, comorbidity, and use of medications for cardiovascular disease and gout. Hazard ratios and 95% confidence intervals were calculated.<h4>Results</h4>In this observational cohort study, of the 1,684,314 eligible people, 116,097 developed incident AMD (6.9%). Incidence rates of AMD per 1,000 person-years were 20.1 for people with gout and 11.7 for people without gout. In multivariable-adjusted analyses, a diagnosis of gout was significantly associated with a higher risk of incident AMD with a hazard ratio of 1.39 (95% CI, 1.35, 1.43). This association was confirmed in sensitivity analyses that substituted Charlson-Romano comorbidity index continuous score with either a categorical Charlson-Romano comorbidity index score or individual Charlson-Romano index comorbidities plus hypertension, hyperlipidemia and coronary artery disease. Other covariates significantly associated with higher hazards of incident AMD were older age, female gender, White race/ethnicity, and higher Charlson-Romano comorbidity index score.<h4>Conclusions</h4>We noted a novel association of gout with AMD in the elderly. Future studies should investigate the pathways that mediate this association.
format Article
id doaj-art-7b2430a5fd48478fbab7b05722cb4529
institution DOAJ
issn 1932-6203
language English
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-7b2430a5fd48478fbab7b05722cb45292025-08-20T02:54:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01137e019956210.1371/journal.pone.0199562Gout and the risk of age-related macular degeneration in the elderly.Jasvinder A SinghJohn D Cleveland<h4>Objective</h4>To assess whether gout is associated with incident age-related macular degeneration (AMD).<h4>Methods</h4>We used the 5% Medicare claims data from 2006-12 for all beneficiaries who were enrolled in Medicare fee-for-service (Parts A, B) and not enrolled in a Medicare Advantage Plan, and resided in the U.S. People were censored at the occurrence of new diagnosis of AMD, death or the end of study (12/31/2012), whichever occurred first. We used multivariable-adjusted Cox regression analyses to assess the association of gout with incident AMD, adjusted for demographics, comorbidity, and use of medications for cardiovascular disease and gout. Hazard ratios and 95% confidence intervals were calculated.<h4>Results</h4>In this observational cohort study, of the 1,684,314 eligible people, 116,097 developed incident AMD (6.9%). Incidence rates of AMD per 1,000 person-years were 20.1 for people with gout and 11.7 for people without gout. In multivariable-adjusted analyses, a diagnosis of gout was significantly associated with a higher risk of incident AMD with a hazard ratio of 1.39 (95% CI, 1.35, 1.43). This association was confirmed in sensitivity analyses that substituted Charlson-Romano comorbidity index continuous score with either a categorical Charlson-Romano comorbidity index score or individual Charlson-Romano index comorbidities plus hypertension, hyperlipidemia and coronary artery disease. Other covariates significantly associated with higher hazards of incident AMD were older age, female gender, White race/ethnicity, and higher Charlson-Romano comorbidity index score.<h4>Conclusions</h4>We noted a novel association of gout with AMD in the elderly. Future studies should investigate the pathways that mediate this association.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199562&type=printable
spellingShingle Jasvinder A Singh
John D Cleveland
Gout and the risk of age-related macular degeneration in the elderly.
PLoS ONE
title Gout and the risk of age-related macular degeneration in the elderly.
title_full Gout and the risk of age-related macular degeneration in the elderly.
title_fullStr Gout and the risk of age-related macular degeneration in the elderly.
title_full_unstemmed Gout and the risk of age-related macular degeneration in the elderly.
title_short Gout and the risk of age-related macular degeneration in the elderly.
title_sort gout and the risk of age related macular degeneration in the elderly
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0199562&type=printable
work_keys_str_mv AT jasvinderasingh goutandtheriskofagerelatedmaculardegenerationintheelderly
AT johndcleveland goutandtheriskofagerelatedmaculardegenerationintheelderly